Suchergebnisse - "Wang, Yanxia"

PubPharm (9)

1

Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older : A randomized, double-blind, controlled study

enthalten in: Vaccine | 2024

von Huang, L. | Chen, Z. | Song, Y. | +9

2

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old : Randomized, blinded, parallel controlled phase III clinical study

enthalten in: Human vaccines & immunotherapeutics | 2023

von Huang, X. | Liang, J. | Huang, L. | +18

3

Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine : a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Feng, G. | Jiang, D. | Han, W. | +11

4

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China : Results from two studies

enthalten in: Human vaccines & immunotherapeutics | 2022

von Liu, X. | Park, J. | Xia, S. | +12

5

Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years : A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial

enthalten in: Vaccine | 2022

von Zhang, Y. | Wang, Y. | Jia, C. | +21

6

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine : A randomized, double-blind, active-controlled phase 1 clinical trial

enthalten in: Vaccine | 2021

von Wang, Y. | Zhang, Y. | Wu, H. | +11

7

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV : a randomised, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2021

von Xia, S. | Zhang, Y. | Wang, Y. | +29

8

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes : Interim Analysis of 2 Randomized Clinical Trials

enthalten in: JAMA | 2020

von Xia, S. | Duan, K. | Zhang, Y. | +34

CommentIn: JAMA. 2020 Sep 8;324(10):943-945. - PMID 32789500

9

Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children : a double-blind, randomized phase III trial

enthalten in: Human vaccines & immunotherapeutics | 2019

von Huang, L. | Chen, Z. | Hu, Y. | +11

1
[1]